PHARMACEUTICAL Society of Australia National President, Dr Chris Freeman, will continue in the role until at least 01 July 2021, after securing the support of the organisation's National Board today.
With the COVID-19 pandemic forcing the PSA to postpone branch committee elections scheduled to take place between 14 Apr and 11 May (PD 09 Mar), the terms of State, Territory and National Boards were extended by 12 months (PD 20 Apr), with the National Board re-electing Freeman as President.
The Board also re-elected Victorian Branch member, Michelle Lynch, as one of two Vice Presidents, alongside ACT Branch President, Renae Beardmore.
Freeman, who became the first PSA President to co-sign sections of a Community Pharmacy Agreement, said it was a honour to be re-elected to the role he was appointed to in Dec 2018, when Dr Shane Jackson stepped down.
"I have been so proud of the way pharmacists have adapted, innovated and cared for their patients and communities during the recent bushfires and COVID-19 pandemic, and it is a privilege to be able to continue in this role," he said.
"While there are challenges facing the profession there are also some great opportunities and I am looking forward to helping our members grasp these opportunities to build their professional careers, while also improving the health of Australians.
"For the first time in 30 years PSA is a signatory in the Community Pharmacy Agreement, our advocacy and policy work will continue as we focus on extending support for the recommendations in our Pharmacists in 2023 action plan and medicine safety reports.
"I congratulate both Michelle and Renae on their appointments and I am thrilled to be working with two very talented pharmacists and health professionals."
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Jun 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Jun 20
